RXFP1 Receptor Activation by Relaxin-2 Induces Vascular Relaxation in Mice via a Gαi2-Protein/PI3Kß/γ/Nitric Oxide-Coupled Pathway

Endothelial dysfunction and vascular disease - a 30th anniversary update

(2016) P. M. Vanhoutte et al.   Acta Physiologica

Better understanding of phosphoinositide 3-kinase (PI3K) pathways in vasculature: Towards precision therapy targeting angiogenesis and tumor blood supply

(2016) D. Tsvetkov et al.   BIOCHEMISTRY-MOSCOW

Time-dependent activation of prostacyclin and nitric oxide pathways during continuous i.v. infusion of serelaxin (recombinant human H2 relaxin)

(2016) C H Leo et al.   BRITISH JOURNAL OF PHARMACOLOGY

A Clinical Perspective: Contribution of Dysfunctional Perivascular Adipose Tissue (PVAT) to Cardiovascular Risk

(2016) Xiaoming Lian et al.   CURRENT HYPERTENSION REPORTS

Triazine herbicides inhibit relaxin signaling and disrupt nitric oxide homeostasis

(2016) Si Eun Park et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

The Role of DPO-1 and XE991-Sensitive Potassium Channels in Perivascular Adipose Tissue-Mediated Regulation of Vascular Tone

(2016) Dmitry Tsvetkov et al.   Frontiers in Physiology

Increased superoxide production and altered nitric oxide-mediated relaxation in the aorta of young but not old male relaxin-deficient mice

(2015) Hooi H. Ng et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Platelet Giprotein Gαi2is an essential mediator of thrombo-inflammatory organ damage in mice

(2015) Vasudharani Devanathan et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The experimental power of FR900359 to study Gq-regulated biological processes

(2015) Ramona Schrage et al.   Nature Communications

Isoform-Specific Functions of Phosphoinositide 3-Kinases: p110  but Not p110  Promotes Optimal Allergic Responses In Vivo

(2014) K. Ali et al.   JOURNAL OF IMMUNOLOGY

Gαi2- and Gαi3-Deficient Mice Display Opposite Severity of Myocardial Ischemia Reperfusion Injury

(2014) David Köhler et al.   PLoS One

Relaxin Suppresses Atrial Fibrillation by Reversing Fibrosis and Myocyte Hypertrophy and Increasing Conduction Velocity and Sodium Current in Spontaneously Hypertensive Rat Hearts

(2013) Ashish Parikh et al.   CIRCULATION RESEARCH

Relaxin Treatment Reverses Insulin Resistance in Mice Fed a High-Fat Diet

(2013) Jeffrey S. Bonner et al.   DIABETES

Localization of relaxin receptors in arteries and veins, and region-specific increases in compliance and bradykinin-mediated relaxation after in vivo serelaxin treatment

(2013) Maria Jelinic et al.   FASEB JOURNAL

Masked Hypertension and Atherogenesis: The Impact of Apelin and Relaxin Plasma Levels

(2013) Dimitris P. Papadopoulos et al.   Journal of Clinical Hypertension

Relaxin induces rapid, transient vasodilation in the microcirculation of hamster skeletal muscle

(2013) Jordan M Willcox et al.   JOURNAL OF ENDOCRINOLOGY

Primary cilium migration depends on G-protein signalling control of subapical cytoskeleton

(2013) Jerome Ezan et al.   NATURE CELL BIOLOGY

Competition for Gβγ dimers mediates a specific cross-talk between stimulatory and inhibitory G protein α subunits of the adenylyl cyclase in cardiomyocytes

(2013) Hans-Jörg Hippe et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

Relaxin Family Peptides and Their Receptors

(2013) R. A. D. Bathgate et al.   PHYSIOLOGICAL REVIEWS

G i2 Is the Essential G i Protein in Immune Complex-Induced Lung Disease

(2012) K. Wiege et al.   JOURNAL OF IMMUNOLOGY

Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial

(2012) John R Teerlink et al.   LANCET

Structure and dynamics of the M3 muscarinic acetylcholine receptor

(2012) Andrew C. Kruse et al.   NATURE

Relaxin Induces Rapid Dilation of Rodent Small Renal and Human Subcutaneous Arteries via PI3 Kinase and Nitric Oxide

(2011) Jonathan T. McGuane et al.   ENDOCRINOLOGY

Relaxin

(2010) Jason Grossman et al.   Cardiology in Review

Central and peripheral administration of human relaxin-2 to adult male rats inhibits food intake

(2010) B. M. C. McGowan et al.   DIABETES OBESITY & METABOLISM

Unveiling the Vasodilatory Actions and Mechanisms of Relaxin

(2010) Kirk P. Conrad   HYPERTENSION

Membrane receptors: Structure and function of the relaxin family peptide receptors

(2010) Roy C.K. Kong et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Resolving the Unconventional Mechanisms Underlying RXFP1 and RXFP2 Receptor Function

(2009) Brigham J. Hartley et al.   Annals of the New York Academy of Sciences

Cardiovascular effects of relaxin: from basic science to clinical therapy

(2009) Xiao-Jun Du et al.   Nature Reviews Cardiology

Relaxin family peptide receptors – from orphans to therapeutic targets

(2008) Emma T. van der Westhuizen et al.   DRUG DISCOVERY TODAY

Glucocorticoid-Related Signaling Effects in Vascular Smooth Muscle Cells

(2008) Gergö A. Molnar et al.   HYPERTENSION

Regulation of Receptor Signaling by Relaxin A Chain Motifs

(2008) Jae-Il Park et al.   JOURNAL OF BIOLOGICAL CHEMISTRY